Ann: Completion of Placement, page-302

Of course management cannot push it to $1.08 because they were poised to sell, at least some of them and some of their shares. That comment is insensitive.
Pre FDA it was 20 cents, and now bod is saying its 31 cents. Was a 10 year work worth just $11m? I don't believe so. The bod simply had no business acumen to do a CR. If there is no market, where is Lbt? Why do you imply that mgt has got nothing to do with market sentiment? Why do you think Lbt should ignore and not work with the market? It was an opportunity wasted.